
Tylenol maker Kenvue exceeds profit estimates, plans 4% job cuts
Tylenol maker Kenvue exceeds profit estimates, plans 4% job cuts
May 7 (Reuters) – Kenvue (KVUE.N), opens new tab beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker’s efforts to expand its key brands.
Since its spinoff from Johnson & Johnson (JNJ.N), opens new tab in May last year, Kenvue has focused on its 15 priority brands to boost growth and said in February it would increase its advertising spending by 15%, or about $300 million, during the year.
The company said on Tuesday it targets pre-tax gross savings of about $350 million annually by 2026 through the cost-cutting program, but will incur $275 million each in restructuring expenses in 2024 and 2025.
Kenvue posted an adjusted profit of 28 cents per share for the first quarter, beating analysts’ estimates of 26 cents.
The self-care segment – which includes cough and cold medicine such as Tylenol and Benadryl – recorded $1.70 billion in net sales, up 3.5% year-on-year and above the average analyst estimate of $1.56 billion, according to LSEG data.
Kenvue’s skin health and beauty segment, consisting of brands including Neutrogena and Clean & Clear, recorded a 5% drop in first-quarter sales to $1.05 billion, but largely in line with estimates.
The company has pushed to improve the presence of its skin health products on store shelves in the U.S. as it looks to reverse sluggish sales over the last few quarters.
The essential health segment, housing brands such as Listerine, Band-Aid and Stayfree, recorded $1.14 billion in sales, up 3.7%, but below analysts’ estimate of $1.17 billion.
The New Jersey-based company posted first-quarter revenue of $3.89 billion, beating estimates of $3.79 billion.
The company maintained its annual profit forecast range of between $1.10 to $1.20 per share.
(Except for the headline, this story has not been edited by VoM News staff and is published from syndicated feed)
Latest Posts
- Britain’s FTSE indexes climb as consumer earnings boost offsets banks, energy drag
July 28, 2026 | Breaking News, Business, Stock Market - Hilton Upgrades Annual Outlook as Luxury Hotel Business Stays Strong
July 28, 2026 | Breaking News, Business, Stock Market - Meta, BlackRock partner on $14 billion El Paso data center
July 28, 2026 | Breaking News, Business, World - Singapore Airlines posts first quarterly loss since pandemic as Air India losses, fuel costs weigh
July 28, 2026 | Breaking News, Business, Stock Market, World - Radico Khaitan Q1 Profit Surges 76% on Strong Premium Liquor Demand
July 28, 2026 | Breaking News, Business, Stock Market - Ambuja Cements Reports 37% Drop in Profit as Weak Volumes and Higher Costs Weigh
July 28, 2026 | Breaking News, Business, Stock Market - Supreme Court Bars Coercive Action Against Students Over CJP-Led NEET-UG 2026 Protests
July 28, 2026 | Breaking News, India - India plans up to quarter of 2027 LPG imports from US, sources say
July 28, 2026 | Breaking News, World - Strong Earthquake Rocks Kyushu, Japan
July 28, 2026 | Breaking News - 39 Amarnath Pilgrims Injured After Bus Skids Off Road in J&K’s Ganderbal
July 28, 2026 | Breaking News, Jammu Kashmir